)
RetinAI US Inc. (RetinAI), subsidiary of Ikerian AG, is a Swiss & US-based software company improving and supporting R&D of drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases.
Focused on the Ophthalmology and Optometry market, RetinAI builds tools to collect, organize and analyze health data from the eyes, enabling healthcare professionals to make the right decisions sooner in healthcare. RetinAI's international team leverages its clinical, technical, and scientific expertise to foster the transition from reactive to preventive medicine for severe eye diseases.
RetinAI’s Discovery® platform is FDA 510k-cleared and CE-Marked under MDR. The company’s AI models for layer, fluid and biomarker segmentation and quantification are CE-Marked under MDR.
Address
Freiburgstrasse 3Bern
3010
Switzerland
Contact Exhibitor
Products
-
RetinAI’s Disease Evaluation Apps, accessed via Heidelberg AppWay in HEYEX 2, provide expert-level OCT analysis. Results, generated as PDFs during patient visits, support retinal disease evaluation an ...
-
Bring Intelligence to your Clinical Workflows & Patient Management Leverage Discovery® for Clinics powered by CE-marked & research use only AI models to enhance patient treatments & deliver the right ...
Videos
News
-
Bern, Switzerland and Boston, U.S.A., 20 February 2024 - Ikerian AG and RetinAI Inc. US (“RetinAI”), a leader in developing software solutions for image processing and artificial intelligence (AI) in ...
-
Bern & Boston, US, 24 June 2024 - Ikerian AG (“Ikerian”) a leader in developing software solutions for medical image and data management and artificial intelligence (AI) in healthcare, today announced ...
-
First close Series B funding round raises USD 8M (CHF 6.73M) led by new investor, Sanoptis, with participation from existing investors the THINC Ventures arm of Topcon Healthcare, Inc, Zürcher Kantona ...